SJSZ glycoprotein (38 kDa) prevents thymus atrophy and enhances expression of IL-2 and IL-12 in diethylnitrosamine-induced hepatocarcinogenesis

International Immunopharmacology

Volumn 13, Issue 3, 2012, Pages 362-369

  Lee, Jin ^a   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

Author keywords

IL 12; IL 2; SJSZ glycoprotein (38 kDa); T bet GATA 3; Thymic atrophy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; DIETHYLNITROSAMINE; GAMMA INTERFERON; GLYCOPROTEIN SJSZ; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; CYTOKINE; GLYCOPROTEIN; IMMUNOLOGIC FACTOR; VEGETABLE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; IMMUNOBLOTTING; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; STYTRAX JAPONICA; TH1 CELL; TH2 CELL; THYMOCYTE; THYMUS ATROPHY; ANIMAL; ATROPHY; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; IMMUNOLOGY; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYTOTHERAPY; SIGNAL TRANSDUCTION; STYRACACEAE; THYMUS;

ANIMALS; ATROPHY; CYTOKINES; DIETHYLNITROSAMINE; GLYCOPROTEINS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERLEUKIN-12; INTERLEUKIN-2; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT PROTEINS; STYRAX; TH1 CELLS; TH2 CELLS; THYMUS GLAND;

EID: 84861465133     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.04.018     Document Type: Article

References (31)

1. Sia D, Villanueva A. Signaling pathways in hepatocellular carcinoma. Oncology 2011;81:18-23.
2. Hsiao YW, Liao KW, Hung SW, Chu RM. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet Immunol Immunopathol 2002;87:19-27.
3. Shi M, Zhang B, Tang ZR, Lei ZY, Wang HF, Feng YY, et al. Autologous cytokineinduced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. World J Gastroenterol 2004;10:1146-51. (Pubitemid 38559390)
4. Hiraoka N. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol 2010;15:544-51.
5. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329-60. (Pubitemid 38680426)
6. Johansson M, Denardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev 2008;222:145-54. (Pubitemid 351430362)
7. Nagai H, Miyaki D, Matsui T, Kanayama M, Higami K, Momiyama K, et al. Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemother Pharmacol 2008;62:959-63.
8. Li X, Zhou XP, Guan YS, Wang YX. Magnetic resonance imaging of hepatocellular carcinoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary Pancreat Dis Int 2005;4:427-32. (Pubitemid 41207548)
9. Ceriello A, Mezza F, Cozzolino S, Pettinato G, Mancini A, Santaniello W, et al. Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamineinduced tumors in rats. Transpl Int 1994;1:S204-7.
10. Newman DJ. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 2008;51:2589-99. (Pubitemid 351620778)
11. Kim TJ. Korean resources plants. first ed. South Korea: Seoul National University Press; 1998.
12. Lee J, Lim KT. Inhibitory effect of phytoglycoprotein (38 kDa) on expression of matrix metalloproteinase-9 in 12-O-tetradecanoylphorbol-13- acetate-treated HepG2cells. Naunyn Schmiedebergs Arch Pharmacol 2011;384:185-96.
13. Neville Jr DM, Glossmann H. Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods Enzymol 1974;32:92-102.
14. Masuko T,Minami A, Iwasaki N,Majima T, Nishimura S, Lee YC. Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem2005;339:69-72. (Pubitemid 40342680)
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
16. Chaplin MF. Monosachcharides. In: Chaplin MF, Kennedy JF, editors. Carbohydrate analysis: a practical approach. NewYork: Oxford University Press Inc; 1994. p. 2-176.
17. Park CH, Oh PS, Lim KT. Inhibitory effect of phytoglycoprotein (115 kDa) on the expression of TNF-alpha and interleukin-1beta via inhibition of MAP kinase in primary cultured mouse thymocytes. Biosci Biotechnol Biochem 2009;73:2196-202.
18. Gabelman BM, Emerman JT. Effects of estrogen, epidermal growth factor, and transforming growth factor-a on the growth of human breast epithelial cells in primary culture. Exp Cell Res 2002;201:113-8.
19. 2+ and protein kinase C signaling for histamine and sulfidoleukotrienes released from human cultured mast cells. Biochem Biophys Res Commun 1999;257:895-900.
20. Patton WF, Dhanak MR, Jacobson BS. Differential partitioning of plasma membrane proteins into the triton X-100-insoluble cytoskeleton fraction during concanavalin A-induced receptor redistribution. J Cell Sci 1989;92:85-91. (Pubitemid 19046860)
21. Oh PS, Lim KT. Plant glycoprotein modulates the expression of interleukin-1beta via inhibition of MAP kinase in HMC-1cells. Biosci Biotechnol Biochem2008;72:2133-40.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. (Pubitemid 34164012)
23. Behboudi S, Boswell S, Williams R. Cell-mediated immune responses to alphafetoprotein and other antigens in hepatocellular carcinoma. Liver Int 2010;30:521-6.
24. Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Miki H. Hepatic resection induces a shift in the Th 1/2 balance toward Th 2 and produces hypermetabolic and hyperhemodynamic states. Hepatogastroenterology 2004;51:1422-7. (Pubitemid 38987497)
25. Fu Y, Paul RD,Wang Y, Lopez DM. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. J Immunol 1989;143:4300-7. (Pubitemid 20012631)
26. Li L, Hsu HC, Grizzle WE, Stockard CR, Ho KJ, Lott P, et al. Cellular mechanism of thymic involution. Scand J Immunol 2003;57:410-22. (Pubitemid 36577900)
27. Li J, Li Q, Feng T, Li K. Aqueous extract of Solanum nigrum inhibit growth of cervical carcinoma (U14) via modulating immune response of tumor bearing mice and inducing apoptosis of tumor cells. Fitoterapia 2008;79:548-56.
28. SubramoniamA, Khandelwal S, Dwivedi PD, Khanna S, Shanker R. Dibutyltin dilaurate induced thymic atrophy and modulation of phosphoinositide pathway of cell signalling in thymocytes of rats. Immunopharmacol Immunotoxicol 1994;16:645-77. (Pubitemid 24374832)
29. Lu HC, Chou FP, Yeh KT, Chang YS, Hsu NC, Chang JG. Expression of protein kinase C family in human hepatocellular carcinoma. Pathol Oncol Res 2010;16:385-91.
30. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 2002;20:55-72. (Pubitemid 34293420)
31. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, Usmani OS, et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 2007;178:2491-8. (Pubitemid 46233450)